Chord Energy, Canada's Enerplus to combine into $11 billion company, with eye on 'premier' position in North Dakota's Williston basin
By Claudia Assis
Chord Energy Corp. and Canada's Enerplus Corp. said late Wednesday they have agreed to merge in an $11 billion stock and cash deal with an eye toward stablishing a "premier" position in North Dakota's Williston shale basin.
Chord (CHRD), itself formed after the merger of Oasis Petroleum and Whiting Petroleum in 2022, said that a combined company would enjoy a "deep, low-cost inventory" in the basin, which also straddles parts of South Dakota and Montana as well as neighboring Canadian provinces.
Don't miss: Chevron, PDC Energy deal holds a few surprises for Wall Street
Shares of Chord jumped 4% in the extended session Wednesday. The deal is the latest in a burgeoning merger-and-acquisitions field for energy companies, including major deals for Exxon Mobil Corp. (XOM) and Chevron Corp. (CVX).
See also: Exxon, Pioneer deal is 'home run' for Exxon
Under the terms of the transaction, a share of Enerplus (CA:ERF) would be exchanged for 0.10125 shares of Chord common stock and $1.84 a share in cash, representing 90% stock and 10% cash consideration, the companies said.
"This combination further strengthens our Williston Basin position and represents a compelling opportunity for both companies' shareholders," Chord Chief Executive Danny Brown said in a statement.
Enerplus' Williston Basin position "brings high-quality inventory, and we are excited to leverage best practices from both companies to create a stronger, more efficient entity," he said.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-21-24 1819ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth